Full Press Release Details
CHASKA, Minn., May 12, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at CDMO Live Europe. The conference will take place May 19-21, 2026, in Rotterdam, Netherlands.
Details regarding Lifecore’s participation are as follows:
If you are interested in meeting with Lifecore during CDMO Live Europe, please reach out to us at:cdmo@lifecore.com.
About Lifecore BiomedicalLifecore Biomedical, Inc. (Nasdaq:LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website atwww.lifecore.com.
Lifecore Biomedical, Inc. Contact Information:
Vida Strategic PartnersStephanie Diaz (Investors)415-675-7401sdiaz@vidasp.com
Jennifer Arcure (Media)917-603-0681jarcure@vidasp.com